Mechanisms of Refractory Hypertension (Carvedilol)
Status:
Withdrawn
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is test whether patients with hypertension refractory to
antihypertensive treatment have evidence of excessive sympathetic (i.e., nervous system)
activity.